Literature DB >> 2334378

The comparative pathogenicity of four serovars of Actinobacillus (Haemophilus) pleuropneumoniae.

R J Rogers1, L E Eaves, P J Blackall, K F Truman.   

Abstract

The pathogenicity of 2 isolates of each of serovars 7, 3, 1 and 2 of Actinobacillus pleuropneumoniae was tested by intranasal inoculation into 60, 6-week-old large white pigs. Four dose rates varying from 0.27 to 560 x 10(6) organisms per pig with 10-fold serial dilutions were used. Surviving pigs were necropsied 7 days after inoculation. The proportion of pigs dying and developing gross lesions following infection was significantly greater for pigs given serotype 1 than for each of the other 3 serotypes, which did not differ significantly from each other. Twelve of 16 pigs given either of the 2 isolates of serovar 1 died after acute illness and 1 of 44 pigs given either of the 2 isolates each of serovars 7, 3 and 2 died. Pigs given serovar 1 showed high temperatures, severe respiratory distress, frothy haemorrhagic nasal discharge and weight loss. Lung lesions were produced in all 16 pigs given serovar 1, in 7 of 14 pigs given serovar 7, 7 of 14 pigs receiving serovar 3 and in 5 of 16 pigs given serovar 2. The lethal infections were characterised by a severe acute fibrinohaemorrhagic necrotising pleuropneumonia, whereas non-lethal cases had lung lesions ranging from necrotising purulent pleuropneumonia to abscessation. Significant differences between isolates in proportions of tissues culture positive for A. pleuropneumoniae for serovars 7 and 2, but not for serovars 3 and 1 suggested that isolates may vary in virulence within serovars, but more detailed studies are needed to clarify this point.

Entities:  

Mesh:

Year:  1990        PMID: 2334378     DOI: 10.1111/j.1751-0813.1990.tb07382.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  8 in total

1.  Distribution of tetracycline resistance genes in Actinobacillus pleuropneumoniae isolates from Spain.

Authors:  Mónica Blanco; César B Gutiérrez-Martin; Elías F Rodríguez-Ferri; Marilyn C Roberts; Jesús Navas
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Clonal analysis of the Actinobacillus pleuropneumoniae population in a geographically restricted area by multilocus enzyme electrophoresis.

Authors:  K Møller; R Nielsen; L V Andersen; M Kilian
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Detection and identification of Actinobacillus pleuropneumoniae serotype 5 by multiplex PCR.

Authors:  T M Lo; C K Ward; T J Inzana
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

4.  Comparative profiling of the transcriptional response to iron restriction in six serotypes of Actinobacillus pleuropneumoniae with different virulence potential.

Authors:  Kirstine Klitgaard; Carsten Friis; Oystein Angen; Mette Boye
Journal:  BMC Genomics       Date:  2010-12-09       Impact factor: 3.969

5.  Detection of Actinobacillus Pleuropneumoniae ApxIV Toxin Antibody in Serum and Oral Fluid Specimens from Pigs Inoculated Under Experimental Conditions.

Authors:  Wendy González; Luis G Giménez-Lirola; Ashley Holmes; Sergio Lizano; Christa Goodell; Korakrit Poonsuk; Panchan Sitthicharoenchai; Yaxuan Sun; Jeffrey Zimmerman
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

6.  Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.

Authors:  Ian J Passmore; Anna Andrejeva; Brendan W Wren; Jon Cuccui
Journal:  BMC Vet Res       Date:  2019-01-03       Impact factor: 2.741

7.  Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.

Authors:  Zhen Dong; Xu-Zheng Zhou; Ji-Chao Sun; Xiao-Bin Meng; Hong-Sheng Li; Fu-Sheng Cheng; Xiao-Juan Wei; Bing Li; Wei-Wei Wang; Ji-Yu Zhang
Journal:  Vet Med Sci       Date:  2019-10-07

8.  Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.

Authors:  Da Sun; Kun Mi; Haihong Hao; Shuyu Xie; Dongmei Chen; Lingli Huang
Journal:  BMC Vet Res       Date:  2020-09-29       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.